Cutler Group LP Adma Biologics, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$1.28 - $1.83 $7,296 - $10,431	-5,700 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$1.09 - $1.66 $1,417 - $2,158	-1,300 Reduced 18.57%	5,700 $0
Q3 2021 Oct 26, 2021	SELL	$1.13 - $1.65 $20,452 - $29,865	-18,100 Reduced 72.11%	7,000 $0
Q2 2021 Jul 19, 2021	SELL	$1.51 - $2.07 $19,932 - $27,323	-13,200 Reduced 34.46%	25,100 $1,000
Q1 2021 Apr 26, 2021	BUY	$1.67 - $2.95 $26,052 - $46,020	15,600 Added 68.72%	38,300 $4,000
Q4 2020 Jan 21, 2021	SELL	$1.8 - $2.56 $47,880 - $68,096	-26,600 Reduced 53.96%	22,700 $7,000
Q3 2020 Oct 27, 2020	BUY	$2.04 - $3.74 $100,572 - $184,382	49,300 New	49,300 $9,000

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.91B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.